Validation pour Ingenuity308

vers la météo de la validation par utilisateur

Ingenuity308

precedent - 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 - suivant

Phrase 6 - PMID ?

In SP hepatocytes , methyl clofenapate increases ( by 17 fold ) expression of SP NODE mRNA that involves cycloheximide 8 hours after initial treatment .

Non annotée
Je ne sais pas
Je n'ai pas trouvé d'analyse satisfaisante

Commentaires :

Analyse 0

                                                                          +-------COMP:N-N(of)-------+                                                               
                +----------COMP:V-N(In)---------+---------OBJ:V-N---------+           +-MOD_ATT:N-ADJ+           +---------------COMP:V-N(after)--------------+      
       +MOD_ATT:+           +MOD_ATT:+-SUBJ:V-N-+COMP:V-N(by+             |           |       +MOD_AT+--SUBJ:V-N-+--OBJ:V-N-+       +MOD+MOD:A+      +MOD_ATT:+      
       |        |           |        |          |           |             |           |       |      |           |          |       |   |     |      |        |      
 In __SP__ hepatocytes , methyl clofenapate increases ( by 17 fold ) expression of __SP__ __NODE__ mRNA that involves cycloheximide 8 hours after initial treatment .
MOD_ATT:N-ADJ (hepatocytes,__SP__)
MOD_ATT:N-N (clofenapate,methyl)
COMP:V-N(In) (increase,hepatocytes)
SUBJ:V-N (increase,clofenapate)
COMP:V-N(by) (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,cycloheximide)
COMP:V-N(after) (involve,treatment)
MOD_ATT:N-ADJ (hour,8)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 1

                                                                          +-------COMP:N-N(of)-------+                                                               
                +----------COMP:V-N(In)---------+---------OBJ:V-N---------+           +-MOD_ATT:N-ADJ+           +---------------COMP:V-N(after)--------------+      
       +MOD_ATT:+           +MOD_ATT:+-SUBJ:V-N-+COMP:V-N(by+             |           |       +MOD_AT+--SUBJ:V-N-+--OBJ:V-N-+       +MOD+MOD:A+      +MOD_ATT:+      
       |        |           |        |          |           |             |           |       |      |           |          |       |   |     |      |        |      
 In __SP__ hepatocytes , methyl clofenapate increases ( by 17 fold ) expression of __SP__ __NODE__ mRNA that involves cycloheximide 8 hours after initial treatment .
MOD_ATT:N-ADJ (hepatocytes,__SP__)
MOD_ATT:N-N (clofenapate,methyl)
COMP:V-N(In) (increase,hepatocytes)
SUBJ:V-N (increase,clofenapate)
COMP:V-N(by) (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,cycloheximide)
COMP:V-N(after) (involve,treatment)
MOD_ATT:N-ADJ (hour,8)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 2

                                                                          +---------------SUBJ:V-N---------------+                                                   
                                                                          +-------COMP:N-N(of)-------+           |                                                   
                +----------COMP:V-N(In)---------+---------OBJ:V-N---------+           +-MOD_ATT:N-ADJ+           +---------------COMP:V-N(after)--------------+      
       +MOD_ATT:+           +MOD_ATT:+-SUBJ:V-N-+COMP:V-N(by+             |           |       +MOD_AT+           +--OBJ:V-N-+       +MOD+MOD:A+      +MOD_ATT:+      
       |        |           |        |          |           |             |           |       |      |           |          |       |   |     |      |        |      
 In __SP__ hepatocytes , methyl clofenapate increases ( by 17 fold ) expression of __SP__ __NODE__ mRNA that involves cycloheximide 8 hours after initial treatment .
MOD_ATT:N-ADJ (hepatocytes,__SP__)
MOD_ATT:N-N (clofenapate,methyl)
COMP:V-N(In) (increase,hepatocytes)
SUBJ:V-N (increase,clofenapate)
COMP:V-N(by) (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,cycloheximide)
COMP:V-N(after) (involve,treatment)
MOD_ATT:N-ADJ (hour,8)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 3

                                                                          +---------------SUBJ:V-N---------------+                                                   
                                                                          +-------COMP:N-N(of)-------+           |                                                   
                +----------COMP:V-N(In)---------+---------OBJ:V-N---------+           +-MOD_ATT:N-ADJ+           +---------------COMP:V-N(after)--------------+      
       +MOD_ATT:+           +MOD_ATT:+-SUBJ:V-N-+COMP:V-N(by+             |           |       +MOD_AT+           +--OBJ:V-N-+       +MOD+MOD:A+      +MOD_ATT:+      
       |        |           |        |          |           |             |           |       |      |           |          |       |   |     |      |        |      
 In __SP__ hepatocytes , methyl clofenapate increases ( by 17 fold ) expression of __SP__ __NODE__ mRNA that involves cycloheximide 8 hours after initial treatment .
MOD_ATT:N-ADJ (hepatocytes,__SP__)
MOD_ATT:N-N (clofenapate,methyl)
COMP:V-N(In) (increase,hepatocytes)
SUBJ:V-N (increase,clofenapate)
COMP:V-N(by) (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,cycloheximide)
COMP:V-N(after) (involve,treatment)
MOD_ATT:N-ADJ (hour,8)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 4

                                                +-----------------------------------------------COMP:V-N(after)-----------------------------------------------+      
                                                |                         +-------COMP:N-N(of)-------+                                                        |      
                +----------COMP:V-N(In)---------+---------OBJ:V-N---------+           +-MOD_ATT:N-ADJ+                                                        |      
       +MOD_ATT:+           +MOD_ATT:+-SUBJ:V-N-+COMP:V-N(by+             |           |       +MOD_AT+--SUBJ:V-N-+--OBJ:V-N-+       +MOD+MOD:A+      +MOD_ATT:+      
       |        |           |        |          |           |             |           |       |      |           |          |       |   |     |      |        |      
 In __SP__ hepatocytes , methyl clofenapate increases ( by 17 fold ) expression of __SP__ __NODE__ mRNA that involves cycloheximide 8 hours after initial treatment .
MOD_ATT:N-ADJ (hepatocytes,__SP__)
MOD_ATT:N-N (clofenapate,methyl)
COMP:V-N(In) (increase,hepatocytes)
SUBJ:V-N (increase,clofenapate)
COMP:V-N(by) (increase,@card@)
OBJ:V-N (increase,expression)
COMP:V-N(after) (increase,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,cycloheximide)
MOD_ATT:N-ADJ (hour,8)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 5

                                                +-----------------------------------------------COMP:V-N(after)-----------------------------------------------+      
                                                |                         +-------COMP:N-N(of)-------+                                                        |      
                +----------COMP:V-N(In)---------+---------OBJ:V-N---------+           +-MOD_ATT:N-ADJ+                                                        |      
       +MOD_ATT:+           +MOD_ATT:+-SUBJ:V-N-+COMP:V-N(by+             |           |       +MOD_AT+--SUBJ:V-N-+--OBJ:V-N-+       +MOD+MOD:A+      +MOD_ATT:+      
       |        |           |        |          |           |             |           |       |      |           |          |       |   |     |      |        |      
 In __SP__ hepatocytes , methyl clofenapate increases ( by 17 fold ) expression of __SP__ __NODE__ mRNA that involves cycloheximide 8 hours after initial treatment .
MOD_ATT:N-ADJ (hepatocytes,__SP__)
MOD_ATT:N-N (clofenapate,methyl)
COMP:V-N(In) (increase,hepatocytes)
SUBJ:V-N (increase,clofenapate)
COMP:V-N(by) (increase,@card@)
OBJ:V-N (increase,expression)
COMP:V-N(after) (increase,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,cycloheximide)
MOD_ATT:N-ADJ (hour,8)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 6

                                                +-----------------------------------------------COMP:V-N(after)-----------------------------------------------+      
                                                |                         +---------------SUBJ:V-N---------------+                                            |      
                                                |                         +-------COMP:N-N(of)-------+           |                                            |      
                +----------COMP:V-N(In)---------+---------OBJ:V-N---------+           +-MOD_ATT:N-ADJ+           |                                            |      
       +MOD_ATT:+           +MOD_ATT:+-SUBJ:V-N-+COMP:V-N(by+             |           |       +MOD_AT+           +--OBJ:V-N-+       +MOD+MOD:A+      +MOD_ATT:+      
       |        |           |        |          |           |             |           |       |      |           |          |       |   |     |      |        |      
 In __SP__ hepatocytes , methyl clofenapate increases ( by 17 fold ) expression of __SP__ __NODE__ mRNA that involves cycloheximide 8 hours after initial treatment .
MOD_ATT:N-ADJ (hepatocytes,__SP__)
MOD_ATT:N-N (clofenapate,methyl)
COMP:V-N(In) (increase,hepatocytes)
SUBJ:V-N (increase,clofenapate)
COMP:V-N(by) (increase,@card@)
OBJ:V-N (increase,expression)
COMP:V-N(after) (increase,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,cycloheximide)
MOD_ATT:N-ADJ (hour,8)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 7

                                                +-----------------------------------------------COMP:V-N(after)-----------------------------------------------+      
                                                |                         +---------------SUBJ:V-N---------------+                                            |      
                                                |                         +-------COMP:N-N(of)-------+           |                                            |      
                +----------COMP:V-N(In)---------+---------OBJ:V-N---------+           +-MOD_ATT:N-ADJ+           |                                            |      
       +MOD_ATT:+           +MOD_ATT:+-SUBJ:V-N-+COMP:V-N(by+             |           |       +MOD_AT+           +--OBJ:V-N-+       +MOD+MOD:A+      +MOD_ATT:+      
       |        |           |        |          |           |             |           |       |      |           |          |       |   |     |      |        |      
 In __SP__ hepatocytes , methyl clofenapate increases ( by 17 fold ) expression of __SP__ __NODE__ mRNA that involves cycloheximide 8 hours after initial treatment .
MOD_ATT:N-ADJ (hepatocytes,__SP__)
MOD_ATT:N-N (clofenapate,methyl)
COMP:V-N(In) (increase,hepatocytes)
SUBJ:V-N (increase,clofenapate)
COMP:V-N(by) (increase,@card@)
OBJ:V-N (increase,expression)
COMP:V-N(after) (increase,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,cycloheximide)
MOD_ATT:N-ADJ (hour,8)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 8

                                                                          +-------COMP:N-N(of)-------+                                                               
                +----------COMP:V-N(In)---------+---------OBJ:V-N---------+           +-MOD_ATT:N-ADJ+                      +---------COMP:N-N(after)---------+      
       +MOD_ATT:+           +MOD_ATT:+-SUBJ:V-N-+COMP:V-N(by+             |           |       +MOD_AT+--SUBJ:V-N-+--OBJ:V-N-+       +MOD+MOD:A+      +MOD_ATT:+      
       |        |           |        |          |           |             |           |       |      |           |          |       |   |     |      |        |      
 In __SP__ hepatocytes , methyl clofenapate increases ( by 17 fold ) expression of __SP__ __NODE__ mRNA that involves cycloheximide 8 hours after initial treatment .
MOD_ATT:N-ADJ (hepatocytes,__SP__)
MOD_ATT:N-N (clofenapate,methyl)
COMP:V-N(In) (increase,hepatocytes)
SUBJ:V-N (increase,clofenapate)
COMP:V-N(by) (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,cycloheximide)
COMP:N-N(after) (cycloheximide,treatment)
MOD_ATT:N-ADJ (hour,8)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 9

                                                                          +-------COMP:N-N(of)-------+                                                               
                +----------COMP:V-N(In)---------+---------OBJ:V-N---------+           +-MOD_ATT:N-ADJ+                      +---------COMP:N-N(after)---------+      
       +MOD_ATT:+           +MOD_ATT:+-SUBJ:V-N-+COMP:V-N(by+             |           |       +MOD_AT+--SUBJ:V-N-+--OBJ:V-N-+       +MOD+MOD:A+      +MOD_ATT:+      
       |        |           |        |          |           |             |           |       |      |           |          |       |   |     |      |        |      
 In __SP__ hepatocytes , methyl clofenapate increases ( by 17 fold ) expression of __SP__ __NODE__ mRNA that involves cycloheximide 8 hours after initial treatment .
MOD_ATT:N-ADJ (hepatocytes,__SP__)
MOD_ATT:N-N (clofenapate,methyl)
COMP:V-N(In) (increase,hepatocytes)
SUBJ:V-N (increase,clofenapate)
COMP:V-N(by) (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,cycloheximide)
COMP:N-N(after) (cycloheximide,treatment)
MOD_ATT:N-ADJ (hour,8)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 10

                                                                          +----------------------------------COMP:N-N(after)----------------------------------+      
                                                                          +-------COMP:N-N(of)-------+                                                        |      
                +----------COMP:V-N(In)---------+---------OBJ:V-N---------+           +-MOD_ATT:N-ADJ+                                                        |      
       +MOD_ATT:+           +MOD_ATT:+-SUBJ:V-N-+COMP:V-N(by+             |           |       +MOD_AT+--SUBJ:V-N-+--OBJ:V-N-+       +MOD+MOD:A+      +MOD_ATT:+      
       |        |           |        |          |           |             |           |       |      |           |          |       |   |     |      |        |      
 In __SP__ hepatocytes , methyl clofenapate increases ( by 17 fold ) expression of __SP__ __NODE__ mRNA that involves cycloheximide 8 hours after initial treatment .
MOD_ATT:N-ADJ (hepatocytes,__SP__)
MOD_ATT:N-N (clofenapate,methyl)
COMP:V-N(In) (increase,hepatocytes)
SUBJ:V-N (increase,clofenapate)
COMP:V-N(by) (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,cycloheximide)
MOD_ATT:N-ADJ (hour,8)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 11

                                                                          +----------------------------------COMP:N-N(after)----------------------------------+      
                                                                          +-------COMP:N-N(of)-------+                                                        |      
                +----------COMP:V-N(In)---------+---------OBJ:V-N---------+           +-MOD_ATT:N-ADJ+                                                        |      
       +MOD_ATT:+           +MOD_ATT:+-SUBJ:V-N-+COMP:V-N(by+             |           |       +MOD_AT+--SUBJ:V-N-+--OBJ:V-N-+       +MOD+MOD:A+      +MOD_ATT:+      
       |        |           |        |          |           |             |           |       |      |           |          |       |   |     |      |        |      
 In __SP__ hepatocytes , methyl clofenapate increases ( by 17 fold ) expression of __SP__ __NODE__ mRNA that involves cycloheximide 8 hours after initial treatment .
MOD_ATT:N-ADJ (hepatocytes,__SP__)
MOD_ATT:N-N (clofenapate,methyl)
COMP:V-N(In) (increase,hepatocytes)
SUBJ:V-N (increase,clofenapate)
COMP:V-N(by) (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,cycloheximide)
MOD_ATT:N-ADJ (hour,8)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 12

                                                                          +---------------SUBJ:V-N---------------+                                                   
                                                                          +-------COMP:N-N(of)-------+           |                                                   
                +----------COMP:V-N(In)---------+---------OBJ:V-N---------+           +-MOD_ATT:N-ADJ+           |          +---------COMP:N-N(after)---------+      
       +MOD_ATT:+           +MOD_ATT:+-SUBJ:V-N-+COMP:V-N(by+             |           |       +MOD_AT+           +--OBJ:V-N-+       +MOD+MOD:A+      +MOD_ATT:+      
       |        |           |        |          |           |             |           |       |      |           |          |       |   |     |      |        |      
 In __SP__ hepatocytes , methyl clofenapate increases ( by 17 fold ) expression of __SP__ __NODE__ mRNA that involves cycloheximide 8 hours after initial treatment .
MOD_ATT:N-ADJ (hepatocytes,__SP__)
MOD_ATT:N-N (clofenapate,methyl)
COMP:V-N(In) (increase,hepatocytes)
SUBJ:V-N (increase,clofenapate)
COMP:V-N(by) (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,cycloheximide)
COMP:N-N(after) (cycloheximide,treatment)
MOD_ATT:N-ADJ (hour,8)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 13

                                                                          +---------------SUBJ:V-N---------------+                                                   
                                                                          +-------COMP:N-N(of)-------+           |                                                   
                +----------COMP:V-N(In)---------+---------OBJ:V-N---------+           +-MOD_ATT:N-ADJ+           |          +---------COMP:N-N(after)---------+      
       +MOD_ATT:+           +MOD_ATT:+-SUBJ:V-N-+COMP:V-N(by+             |           |       +MOD_AT+           +--OBJ:V-N-+       +MOD+MOD:A+      +MOD_ATT:+      
       |        |           |        |          |           |             |           |       |      |           |          |       |   |     |      |        |      
 In __SP__ hepatocytes , methyl clofenapate increases ( by 17 fold ) expression of __SP__ __NODE__ mRNA that involves cycloheximide 8 hours after initial treatment .
MOD_ATT:N-ADJ (hepatocytes,__SP__)
MOD_ATT:N-N (clofenapate,methyl)
COMP:V-N(In) (increase,hepatocytes)
SUBJ:V-N (increase,clofenapate)
COMP:V-N(by) (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,cycloheximide)
COMP:N-N(after) (cycloheximide,treatment)
MOD_ATT:N-ADJ (hour,8)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 14

                                                                          +-------COMP:N-N(of)-------+                                                               
                +----------COMP:V-N(In)---------+---------OBJ:V-N---------+           +-MOD_ATT:N-ADJ+---------------------COMP:N-N(after)--------------------+      
       +MOD_ATT:+           +MOD_ATT:+-SUBJ:V-N-+COMP:V-N(by+             |           |       +MOD_AT+--SUBJ:V-N-+--OBJ:V-N-+       +MOD+MOD:A+      +MOD_ATT:+      
       |        |           |        |          |           |             |           |       |      |           |          |       |   |     |      |        |      
 In __SP__ hepatocytes , methyl clofenapate increases ( by 17 fold ) expression of __SP__ __NODE__ mRNA that involves cycloheximide 8 hours after initial treatment .
MOD_ATT:N-ADJ (hepatocytes,__SP__)
MOD_ATT:N-N (clofenapate,methyl)
COMP:V-N(In) (increase,hepatocytes)
SUBJ:V-N (increase,clofenapate)
COMP:V-N(by) (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,cycloheximide)
MOD_ATT:N-ADJ (hour,8)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 15

                                                                          +-------COMP:N-N(of)-------+                                                               
                +----------COMP:V-N(In)---------+---------OBJ:V-N---------+           +-MOD_ATT:N-ADJ+---------------------COMP:N-N(after)--------------------+      
       +MOD_ATT:+           +MOD_ATT:+-SUBJ:V-N-+COMP:V-N(by+             |           |       +MOD_AT+--SUBJ:V-N-+--OBJ:V-N-+       +MOD+MOD:A+      +MOD_ATT:+      
       |        |           |        |          |           |             |           |       |      |           |          |       |   |     |      |        |      
 In __SP__ hepatocytes , methyl clofenapate increases ( by 17 fold ) expression of __SP__ __NODE__ mRNA that involves cycloheximide 8 hours after initial treatment .
MOD_ATT:N-ADJ (hepatocytes,__SP__)
MOD_ATT:N-N (clofenapate,methyl)
COMP:V-N(In) (increase,hepatocytes)
SUBJ:V-N (increase,clofenapate)
COMP:V-N(by) (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
SUBJ:V-N (involve,mRNA)
OBJ:V-N (involve,cycloheximide)
MOD_ATT:N-ADJ (hour,8)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 16

                                                                          +----------------------------------COMP:N-N(after)----------------------------------+      
                                                                          +---------------SUBJ:V-N---------------+                                            |      
                                                                          +-------COMP:N-N(of)-------+           |                                            |      
                +----------COMP:V-N(In)---------+---------OBJ:V-N---------+           +-MOD_ATT:N-ADJ+           |                                            |      
       +MOD_ATT:+           +MOD_ATT:+-SUBJ:V-N-+COMP:V-N(by+             |           |       +MOD_AT+           +--OBJ:V-N-+       +MOD+MOD:A+      +MOD_ATT:+      
       |        |           |        |          |           |             |           |       |      |           |          |       |   |     |      |        |      
 In __SP__ hepatocytes , methyl clofenapate increases ( by 17 fold ) expression of __SP__ __NODE__ mRNA that involves cycloheximide 8 hours after initial treatment .
MOD_ATT:N-ADJ (hepatocytes,__SP__)
MOD_ATT:N-N (clofenapate,methyl)
COMP:V-N(In) (increase,hepatocytes)
SUBJ:V-N (increase,clofenapate)
COMP:V-N(by) (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,cycloheximide)
MOD_ATT:N-ADJ (hour,8)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 17

                                                                          +----------------------------------COMP:N-N(after)----------------------------------+      
                                                                          +---------------SUBJ:V-N---------------+                                            |      
                                                                          +-------COMP:N-N(of)-------+           |                                            |      
                +----------COMP:V-N(In)---------+---------OBJ:V-N---------+           +-MOD_ATT:N-ADJ+           |                                            |      
       +MOD_ATT:+           +MOD_ATT:+-SUBJ:V-N-+COMP:V-N(by+             |           |       +MOD_AT+           +--OBJ:V-N-+       +MOD+MOD:A+      +MOD_ATT:+      
       |        |           |        |          |           |             |           |       |      |           |          |       |   |     |      |        |      
 In __SP__ hepatocytes , methyl clofenapate increases ( by 17 fold ) expression of __SP__ __NODE__ mRNA that involves cycloheximide 8 hours after initial treatment .
MOD_ATT:N-ADJ (hepatocytes,__SP__)
MOD_ATT:N-N (clofenapate,methyl)
COMP:V-N(In) (increase,hepatocytes)
SUBJ:V-N (increase,clofenapate)
COMP:V-N(by) (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (involve,expression)
OBJ:V-N (involve,cycloheximide)
MOD_ATT:N-ADJ (hour,8)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)